With a burgeoning pipeline of drugs deeply advanced, clinical stage biopharmaceuticals company Pharmaxis (ASX: PXS) has streamlined its business with the sale of its mannitol respiratory business (MBU) and will now will focus their resources towards a much larger commercial opportunity in blood cancers haematological malignancies, aka blood cancers. The definitive sale agreement of its
Read More
B2B pharmaceutical company and medical cannabis cultivator ECS Botanics (ASX: ECS) has secured an offtake agreement to supply medical cannabis dried flowers to Perth-based medical cannabis company MediCann Health over the next five years.
Read More
The common theme of market strategists over the past 6 months – basically since the Credit Suisse and Silicon Valley Bank events in March – is that the global economy will face a credit crunch that causes a recession. Even though this has been subsequently and self-evidently shown to be an incorrect forecast, the same
Read More
The XJO is expected to open lower this morning. Most U.S sectors were down – it was only tech that really helped their market finish flat which doesn’t have nearly as much weight locally. Furthermore, yesterday our market was hopeful for a relief rally in the U.S, heralded by their strong futures during our session,
Read More
Australian digital health company 1st Group’s (ASX: 1ST) telehealth subsidiary, Visionflex, has clinched a significant deal with the Western Australia Primary Health Alliance (WAPHA). This marks Visionflex’s second purchase order from WAPHA for an additional 75 Visionflex Clinical Telehealth Carts, valued at over $1.1 million. The initial order, placed in August 2023, consisted of the
Read More
Advanced marine propulsion and stabilisation system developer VEEM (ASX: VEE) has signed an exclusive agreement with nautical engineering company Sharrow Engineering.
Read More